XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Verfügbar ab:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (Internationale Bezeichnung):

levocetirizine dihydrochloride

Darreichungsform:

Oral Liquid

Zusammensetzung:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Verabreichungsweg:

Oral

Einheiten im Paket:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Verschreibungstyp:

(S2) Pharmacy Medicine

Anwendungsgebiete:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Produktbesonderheiten:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2010-01-19